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Abstract  26 
Normal mammalian early embryonic development involves apoptosis of blastomeres as a 27 
remodeling process during differentiation, starting at the blastocyst stage. Genomic DNA has 28 
been recently detected in the blastocoele fluid of human embryos and has been amplified by 29 
real-time PCR to diagnose the sex of in vitro produced human embryos. This new approach 30 
varies from conventional Preimplantation Genetic Diagnosis (PGD) in that no cells are extracted 31 
from the embryo and only the blastocoele fluid is aspirated and used as a DNA sample for 32 
diagnosis. In the present work, we investigated whether the blastocoele fluid of equine 33 
preimplantation embryos contain nuclear DNA and if this DNA could be used to diagnose the 34 
sex of the embryos by conventional PCR, using specific primers that target the TSPY and AMEL 35 
equine genes. The sex of 11 out of 13 in vivo produced embryos and of 4 out of 5 in vitro 36 
produced embryos was successfully diagnosed. The PCR amplification product was analyzed 37 
using genetic sequencing demonstrating that the DNA present in blastocoele fluid was genomic. 38 
Additionally, after polyacrylamide gel electrophoresis and silver staining, the blastocoele fluid 39 
from three different embryos produced a ladder pattern characteristic of DNA fragmented during 40 
apoptosis. Therefore, the results presented in this work demonstrate that blastocoele fluid from 41 
in vivo and in vitro produced equine embryos contain nuclear DNA which is probably originated 42 
by apoptosis of embryonic cells and this DNA could be used to diagnose the sex of 43 
preimlpantation embryos by conventional PCR.  44 
 45 
Keywords 46 
Preimplantation Genetic Diagnosis, Equine, Preimplantation embryo, Sex determination, 47 
Apoptosis.48 
 49 
1. Introduction 50 
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Apoptosis, a form of cell death that affects isolated cells, is characterized by nucleus and DNA 51 
fragmentation, cytoplasm condensation, membrane changes and cell death without lysis or 52 
damage to neighboring cells. It is a normal physiological phenomenon that occurs in 53 
multicellular organisms and is genetically determined.   54 
During early development of mammalian embryos, the blastomeres differentiate at the 55 
blastocyst stage into two different cell lineages: the trophoblast, which will give rise to 56 
extraembryonic tissue, and the inner cell mass, which forms the fetus. In a normal developing 57 
embryo, these two cell lineages undergo apoptosis [1], a process that occurs as a mechanism 58 
to eliminate unwanted or genetically defective cells.  59 
Recently, Palini et al. [2] reported for the first time the presence of genomic DNA in the 60 
blastocoele fluid of in vitro produced human embryos. These authors demonstrated that this 61 
DNA was amplifiable by real-time PCR and hypothesized that this DNA could be released into 62 
the blastocoele cavity from cells undergoing apoptosis. In addition, they were able to determine 63 
the sex of 26 out of 29 human embryos by amplifying the DNA present in the blastocoele fluid 64 
from these embryos.  65 
Preimplantation Genetic Diagnosis (PGD) allows the identification of specific genetic traits of 66 
early embryos. Preimplantation Genetic Diagnosis was first used in humans more than twenty 67 
years ago [3] and has also been used in bovine [4], caprine [5] and equine [6] preimplantation 68 
embryos. Conventional PGD involves obtaining blastomeres by biopsy from early embryos, 69 
which has to be performed carefully in order to avoid impairing the viability of the embryo.  70 
Blastocoele fluid aspiration is a simpler technique to obtain genomic DNA from embryos since 71 
only fluid is collected from the blastocysts and therefore, if it can be used to determine the sex 72 
of preimplantation embryos efficiently, gender by PGD could be determined faster. This is 73 
important if PGD is performed to avoid transferring embryos of the undesired sex, since the 74 
determination needs to be completed on the same day of uterine flush. In some horse breeds, 75 
like Polo Argentino, females are preferred to males due to their higher abilities for performance 76 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 
4 
in polo.  77 
Therefore, the aim of this work was to study if 1) the sex of in vivo and in vitro produced equine 78 
embryos can be determined by amplification of DNA from blastocoele fluid, 2) the blastocoele 79 
fluid of preimplantation equine embryos contain nuclear DNA and 3) the DNA present in 80 
blastocoele fluid is originated by apoptosis. 81 
 82 
2. Materials and Methods 83 
Animal Care and Welfare 84 
The protocol (011/2013) for this study was approved by the Committee on the Ethics of Animal 85 
Experiments of the Universidad Nacional de San Martín following the recommendations in the 86 
Guide for the Care and Use of Animals of the National Institute of Health.  87 
 88 
2.1 Experiment 1: Gender determination by amplification of DNA from blastocoele fluid from in 89 
vivo and in vitro produced equine embryos. 90 
 91 
2.1.1 In vivo produced equine embryos 92 
Ovarian follicular development in estrous crossbreed donor mares was monitored daily using 93 
ultrasound scanning. When the dominant follicle(s) reached ≥35 mm in diameter, the mares 94 
were artificially inseminated once with fresh semen from a fertile stallion and were administered  95 
1 mg of a GnRH analog (BioRelease deslorelin acetate, BET Pharm, Lex, KY, USA) i.m. for 96 
ovulation induction. Fixed twice daily (7AM / 7 PM) ultrasound examinations of the ovaries were 97 
continued to diagnose the occurrence of ovulation (Day 0). 98 
Exactly on Day 8 after ovulation detection on each donor mare, they were placed in stocks and 99 
embryos were non surgically collected as described previously by Losinno et al. [7] using sterile 100 
Ringer Lactate as flushing media and in line embryo filter. The residual medium in the filter 101 
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was transferred to a sterile plastic Petri dish and the embryo was searched using a 102 
stereomicroscope under a laminar flow. Once the embryo was located, it 103 
was morphologically graded using the scale proposed by McKinnon and Squires [8]. Only 104 
morphologically normal (Grade 1) and blastocyst stage embryos were included in the study.  105 
 106 
2.1.2 Equine embryos produced in vitro by Intracytoplasmic Sperm Injection (ICSI) 107 
Ovaries were obtained from a pool of mares with unknown reproductive history from an equine 108 
slaughterhouse located 50 km from our laboratory. Oocytes were obtained by aspiration of 109 
follicles with a 19 G needle connected to an aspiration pump and matured in vitro for 18-22 h in 110 
50-µL microdroplets under mineral oil of TCM199 supplemented with 1 mM glutamine, 0.19 mM 111 
sodium pyruvate, 5 µg/mL FSH (Bioniche), 100 ng/mL EGF, 100 ng/mL IGF-I and 10 % Fetal 112 
Bovine Serum (FBS) (Gibco, South America). After in vitro maturation, expanded cumulus-113 
oocyte complexes were incubated in a 0.1 % hyaluronidase solution for 10 min and their 114 
cumulus cells removed by vigorous pipetting through a fine-bore glass pipette.  115 
All oocytes with a visible polar body and an intact cytoplasm were selected for injection and ICSI 116 
was performed as described previously by Palermo et al. [9]. Briefly, sperm cells were 117 
immobilized by disruption of the plasma membrane with the injection pipette. Each oocyte was 118 
injected with one stallion sperm while held in place by the holding pipette. All injected oocytes 119 
were cultured in vitro in SOFm with 19 mM D-glucose with 10 % FBS at 38º C, in 7 % O2 and 5 120 
% CO2 for 48 h [10]. At this time, oocytes were observed under light microscopy and all cleaved 121 
embryos were cultured for at least 5.5 more days. 122 
 123 
2.1.3 Blastocoele fluid collection 124 
In vivo or in vitro produced blastocyst stage embryos were placed in 50-µL microdroplets of 125 
Dulbecco modified Phosphate Buffered Saline without calcium and magnesium (Sigma) 126 
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supplemented with 10 % FBS and 50 µg/mL of gentamicin (working medium) under mineral oil, 127 
on an inverted microscope equipped with a Nikon-Narishige micromanipulation system. 128 
Embryos were held in place by suction of a holding pipette and the inner cell mass was placed 129 
90° clockwise away from the holding pipette. Then, the embryo capsule of in vivo produced 130 
embryos or the zona pellucida of in vitro produced embryos was punctured with a beveled 131 
micropipette (9 µm ID, ORIGIO, Humagen Pipets, USA). All the blastocoele fluid was aspirated 132 
and, using the same micropipette, discharged on a 1-µL microdroplet of working medium. The 133 
microdroplet containing the blastocoele fluid was examined under the microscope for the 134 
presence of embryonic cells that could have been accidentally aspirated during the procedure. 135 
Only samples that did not contain any cells were included in the study. The blastocoele fluid 136 
aspiration procedure (Figure 1) was performed by manual suction, connecting the biopsy 137 
micropipette to a disposable syringe. The complete volume of the microdroplet containing the 138 
blastocoele fluid was transferred to a 0.2-mL DNAse-free tube containing 4 µL of DNAse-free 139 
water. The operators performing the blastocoele fluid collection wore lab coats, non-powdered 140 
gloves, masks and caps. The micropipettes used for blastocoele fluid collection were replaced 141 
after each procedure, so that each set of pipettes was used for only one embryo.  The tips used 142 
to handle blastocoele fluid samples were sterile, disposable, with filter and were used 143 
individually for each sample.  144 
 145 
 2.1.4 Amplification by PCR of the DNA present in the blastocoele fluid 146 
A duplex PCR was performed to amplify the Y-encoded testis-specific protein (TSPY) and 147 
amelogenin (AMEL) genes. The oligodeoxynucleotide primers used to amplify these two 148 
sequences and the size of the expected amplification products are shown in Table 1. The total 149 
reaction volume was 12.5 mL and contained 6.25 mL MasterMix (Promega, Mi, USA), 0.2 µM 150 
TSPY primers, 0.1 µM AMEL primers, and 3.25 µL of the sample. The thermal cycling 151 
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parameters were 95 °C for 1 min, 35 cycles of 94 °C for 15 s, 58.4 °C for 30 s, 72 °C for 30 s; 152 
and 72 °C for 5 min. The PCR was performed twice, using the same primers and cycling 153 
protocol. In order to monitor a possible DNA contamination, one tube was included as a control 154 
in the first PCR and contained all the necessary components for the PCR, except 3.25 µL of 155 
DNAse-free water were placed in the tube instead of the DNA sample. In the second PCR, 3.25 156 
µL of the amplification product from the first PCR was used as DNA template. All the samples 157 
and reagents for PCR and the amplification products were handled using sterile disposable tips 158 
with filter. The amplification products were electrophoresed on a 2% agarose gel stained with 159 
ethidium bromide and visualized under UV light. 160 
 161 
Table 1. Primers used for sex determination of equine embryos by amplification of DNA in 162 
blastocoele fluid. 163 
Primer Sequence Fragment size 
 (bp) References 
AMEL-F 5'-CCAACCCAACACCACCAGCCAAACCTCCCT-3' 184 (female) 
160/200 (male) 
Hasegawa et 
al [11] AMEL-R 5'-AGCATAGGGGGCAAGGGCTGCAAGGGGAAT-3' 
TSPY-F 5'-GAA GTC AGG CAC ACC AGT GA-3' 
280 Paria et al [12] 
TSPY-R 5'-TAA GGC TGC AGT TGT CAT GC-3' 
 164 
 165 
2.1.5 Survival of in vivo produced embryos after blastocoele fluid aspiration and in vitro culture 166 
Immediately after blastocoele fluid aspiration, seven in vivo produced embryos were placed 167 
individually in 50-µL microdroplets of SOFm with 19 mM D-glucose with 10 % FBS under 168 
mineral oil at 38º C, in 7 % O2 and 5 % CO2 and observed at 24, 48 and 72 h. The diameter of 169 
embryos was registered immediately before blastocoele fluid aspiration and every 24 h during in 170 
vitro culture.  171 
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  172 
2.1.6 Amplification by PCR of the DNA from sampled embryos 173 
After blastocoele fluid aspiration or blastocoele fluid aspiration and in vitro culture for 72 h, all 174 
embryos were sliced into small fragments using a micro-blade and each fragment was placed in 175 
a 0.2-mL DNAse-free tube with 4 µL of DNAse-free water and maintained at -20 °C until 176 
analyzed by PCR. The primers and cycling protocol were the same as with the blastocoele fluid 177 
samples. Results of the amplification of the DNA from sampled embryos were compared with 178 
the results of the amplification of the DNA from the blastocoele fluid samples from the same 179 
embryos. 180 
 181 
2.2 Experiment 2: Genetic sequence analysis of the amplified DNA from blastocoele fluid of in 182 
vivo produced embryos 183 
The band on the agarose gel corresponding to the amplification product of the expected 184 
molecular weight of the specific PCR using TSPY primers from two different samples obtained 185 
from in vivo produced embryos was extracted using the QIAEX DNA extraction kit (Qiagen, CA, 186 
USA), according to the manufacturer's recommendation. The purified fragments were cloned 187 
into pGEMT-easy (Promega) and subsequently propagated in Escherichia coli TOP TEN 188 
(Invitrogen, CA, USA). Bacteria were grown in Luria-Bertani medium (10 g Bacto tryptone, 5 g 189 
yeast extract and 10 g NaCl in 1L water) overnight at 37 °C with stirring. At 18 h of culture, a 190 
midiprep was performed with 150 mL of medium using the Qiagen midi kit (Tip 100, Qiagen), 191 
following the manufacturer's recommendations. The plasmids obtained were quantified by 192 
spectrophotometry and sequenced with SP6 and T7 primers. Sequencing was performed by an 193 
ABI PRISM 3111 sequencer. Sequences were deposited at the National Center for 194 
Biotechnology Information (NCBI) and compared using the Basic Local Alignment Tool (BLAST) 195 
with existing sequences at GenBank. Only sequences with more than 99 % of identity were 196 
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accepted. 197 
 198 
2.3 Experiment 3: DNA ladder assay of blastocoele fluid from in vivo produced embryos 199 
Blastocoele fluid from three different Day-8 in vivo produced equine embryos was obtained as 200 
described in Experiment 1. DNA was purified from blastocoele fluid samples through minispin kit 201 
columns (Qiagen), following the manufacturer's protocol. Electrophoresis was performed in 10 202 
% polyacrylamide gel in 1X TBE buffer (89 mM Tris, 89 mM Boric Acid, 2 mM EDTA) for 2 h at 203 
100 Volts. 204 
After electrophoresis, the tray was disassembled and the gel was washed with purified water for 205 
10 s. Then, the gel was incubated for 10 min in fixing solution (acetic acid in water 7.5 % v/v). 206 
Once completed, the gel was washed with deionized water for 2 min. Additionally, a pre-207 
treatment was performed with a solution of formaldehyde (15 % in water v/v) for 10 min, then 208 
incubated for 20 min with a silver solution (0.1 g AgNO3 in water) and washed twice with 209 
deionized water for 3 s. The gel was revealed by incubation in developing solution (3 g Na2CO3, 210 
1 mM sodium thiosulfate in 100 mL of water). The reaction was stopped with stop developer 211 
solution (7.5 % acetic acid in water). 212 
 213 
3. Results 214 
3.1 Experiment 1 215 
Thirteen in vivo and five in vitro produced equine embryos were used for this experiment. The 216 
bands observed after PCR and electrophoresis of the amplified female and male samples are 217 
shown in Figure 2. The genetic sex was determined in 11 out of the 13 (84.6 %) and 4 out of the 218 
5 (80 %) blastocoele fluid samples obtained from in vivo and in vitro produced embryos 219 
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respectively. Eight out of the 11 blastocoele fluid samples from the in vivo produced embryos 220 
that amplified were diagnosed as males and three were diagnosed as females, whereas two out 221 
of the four amplified samples from the in vitro produced embryos were diagnosed as males and 222 
two as females. The results obtained by PCR of blastocoele fluid were compared with those 223 
obtained after PCR of fragments of embryos from which the blastocoele fluid was collected. The 224 
sex diagnosed from blastocoele fluid samples was the same as that diagnosed from the 225 
corresponding pieces of embryos in all 15 cases (11 in vivo and 4 in vitro produced embryos 226 
respectively). The two blastocoele fluid samples from in vivo produced embryos and the only 227 
sample from an in vitro produced embryo that failed to amplify after PCR were obtained from 228 
female embryos.  229 
Seven of the thirteen in vivo produced embryos were cultured in vitro and observed every 24 h 230 
for post- blastocoele fluid aspiration survival. Six out of seven embryos reexpanded at 24 h of in 231 
vitro culture and increased their diameter at 48 and 72 h. The average percentage increase in 232 
diameter at the end of the culture period was 73.7%, from a mean of 633 µm to a mean of 1100 233 
µm. Four of the six reexpanded embryos hatched in vitro during the culture period. Figure 3 234 
shows one of the in vivo produced embryos hatching, after 48 h of in vitro culture.  235 
 236 
3.2 Experiment 2 237 
The sequence cloned into pGEMT-easy and plasmid DNA was isolated and purified by spin 238 
Qiaprep miniprep kit (Qiagen, CA, USA), according to the manufacturer's protocol. Then, the 239 
plasmid DNA was compared using BLAST. The fragment obtained after PCR of DNA in the 240 
blastocoele fluid was 100 % identical to a sequence in the Y chromosome of Equus caballus, 241 
sequence ID: AC215855.2, demonstrating that the amplified sequence was genomic DNA. 242 
 243 
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3.3 Experiment 3 244 
This experiment was repeated three times, using blastocoele fluid from three different in vivo 245 
produced equine embryos. Separation of DNA from blastocoele fluid by polyacrylamide gel 246 
electrophoresis and silver staining showed a ladder pattern in all three samples, characteristic of 247 
DNA from cells undergoing apoptosis (Figure 4). 248 
 249 
4. Discussion 250 
Preimplantation Genetic Diagnosis, which allows the detection of genetic traits in early embryos, 251 
is a well-established procedure that involves the collection of one or more cells. Recently, Palini 252 
et al. [2] demonstrated that PGD could also be performed using blastocoele fluid of in vitro 253 
produced human preimplantation embryos, obtained prior to vitrification.  254 
In the present work, we confirmed the findings of Palini et al. [2] by detecting the sex of in vitro 255 
produced equine embryos and showed that this strategy can be applied to in vivo produced 256 
equine embryos as well, using conventional PCR.  257 
Although we were able to diagnose the sex of 11 out of the 13 in vivo produced embryos and of 258 
4 out of the 5 in vitro produced embryos, this technique failed to produce a result in three of the 259 
samples. The diagnosis rate of this technique was high, but further studies with a larger number 260 
of samples will demonstrate whether this efficiency can be improved. Using multi-copy genes for 261 
PCR improves the detection rate in samples with low amounts of DNA, such as those of 262 
blastocoele fluid. The use of blastocoele fluid for PCR is probably limited to multi-copy genes 263 
and not suitable for the detection of other genes that are in single copy. This was evidenced in 264 
Experiment 1, where all three samples that failed to produce an amplification product were from 265 
female embryos, demonstrating that AMEL - being a single-copy gene - was not efficiently 266 
detected. All male samples were diagnosed successfully, using specific primers that targeted 267 
the TSPY gene, which is involved in testicular development and is present in multiple copies in 268 
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the equine genome of male samples [12].  269 
Because of the small amount of DNA present in blastocoele fluid, a double PCR and primers 270 
targeting multicopy genes need to be used to achieve amplification. This methodology is highly 271 
sensitive to DNA contamination and therefore, handling of blastocoele fluid samples and 272 
amplification products needs to be performed with extreme caution. Operators performing the 273 
PCR have to wear proper protection, samples and amplification products need to be handled 274 
using tips with barriers and negative controls have to be included on each step of the protocol.   275 
In Experiment 2, by using specific primers targeting for TSPY and genetic sequencing, we were 276 
able to confirm that the amplified sequence was from Equus caballus DNA located in the Y 277 
chromosome. This result confirms that the DNA in blastocoele fluid used as a template for PCR 278 
was nuclear DNA.  279 
In Experiment 3, we demonstrated that the DNA present in the blastocoele fluid from in vivo 280 
produced embryos is fragmented and shows a characteristic ladder pattern present in cells 281 
undergoing apoptosis. To our knowledge, this is the first report presenting evidence that the 282 
DNA in blastocoele fluid is originated from apoptosis. Tremoleda et al. [13] showed that equine 283 
embryos produced in vitro by ICSI present a much higher number of apoptotic cells than in vivo 284 
produced embryos, with only 4 out of 10 in vivo produced embryos presenting apoptotic cells. In 285 
Experiment 1, we were able to amplify the apoptotic DNA present in blastocoele fluid by PCR, 286 
proving that in vivo produced embryos present enough apoptotic DNA as a template for PCR. 287 
Previous reports have shown that blastomere biopsy of murine embryos produce epigenetic 288 
aberrations in the brain tissue of the offspring [14] and that there is an abnormal development 289 
and function of neurons of mice generated after blastomere biopsy [15]. Blastocoele fluid 290 
collection could be less detrimental to the embryo because no embryonic cells are extracted 291 
during the procedure, is technically simpler than conventional PGD and is performed in less 292 
time. In the present study we observed that a high proportion of aspirated embryos survived and 293 
increased their diameter after in vitro culture for 72 h. Although the pregnancy rates of in vivo or 294 
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in vitro produced equine embryos transferred after blastocoele fluid extraction still needs to be 295 
studied, the in vitro survival of aspirated embryos demonstrates this approach does not impair 296 
their viability. Since it has already been shown that the pregnancy rates of biopsied or intact in 297 
vivo produced equine embryos are not significantly different [16, 17], similar results are 298 
expected using embryos from which only blastocoele fluid and no cells are obtained. In a 299 
previous report, we aspirated ten to thirty blastomeres from each biopsied embryo [17] and 300 
embryos collapsed completely during the biopsy procedure, similar to that observed after 301 
blastocoele fluid collection.  302 
 303 
5. Conclusions 304 
The results presented in this study demonstrate that the sex of in vivo and in vitro produced 305 
equine embryos can be diagnosed using blastocoele fluid as the DNA source for conventional 306 
PCR. Our results also confirm that the DNA amplified by PCR is nuclear DNA and that 307 
fragmented DNA, probably originated from apoptosis of embryonic cells, is present in the 308 
blastocoele fluid of in vivo produced embryos. The large size and consequently, the large 309 
volume of blastocoele fluid present in equine embryos, make the horse a suitable animal model 310 
to study the presence of apoptotic DNA during early development. 311 
 312 
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Figure 1. Blastocoele fluid collection from an in vivo produced equine embryo 500 µm in 373 
diameter. A: In vivo produced equine embryo before blastocoele fluid aspiration; B: The embryo 374 
is punctured with the aspiration micropipette; C: The blastocoele fluid is aspirated; D: The same 375 
embryo as in A after blastocoele fluid collection. 376 
 377 
Figure 2. Electrophoresis in agarose gel of TSPY and AMEL PCR products. M: 50-bp marker; 1: 378 
Female sample, one AMEL band at 184 bp; 2: Male sample, one TSPY band at 280 bp and two 379 
AMEL bands at 160 bp and 200 bp; 3: No DNA control. 380 
 381 
Figure 3. In vivo produced equine embryo. A: After blastocoele fluid aspiration; B: After 48 h of 382 
in vitro culture.  383 
 384 
Figure 4. Polyacrylamide gel electrophoresis and silver staining of blastocoele fluid from an in 385 
vivo produced equine embryo. BF: Blastocoele fluid; M: 50-bp marker. 386 
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Highlights 
 
• Blastocoele fluid of equine preimplantation embryos contains genomic DNA. 
• The DNA present in blastocoele fluid is probably originated by apoptosis of 
blastomeres.  
• Blastocoele fluid contains enough DNA to diagnose preimplantation embryos by 
PGD. 
• Aspiration of the blastocoele fluid does not impair embryo viability. 
 
